Nov 13, 2018 - Jazz Pharmaceuticals plc (JAZZ) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Nov 11, 2018 - Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks
Nov 10, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Nov 09, 2018 - Jazz Pharmaceuticals (NASDAQ:JAZZ) has filed a marketing application in Europe seeking approval for solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor, to improve wakefulness and
Nov 08, 2018 - B. Riley FBR issues rating change for JAZZ
Nov 08, 2018 - Jazz Pharmaceuticals (JAZZ) lowers sales guidance for 2018. Stock declines 14% following the release of third-quarter earnings.
Nov 07, 2018 - Jazz's third-quarter earnings missed the mark, causing some investors to hit the exits today.
Nov 06, 2018 - Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)Q3 2018 Earnings CallNovember 06, 2018 4:30 pm ETExecutivesKatherine A. Littrell - Jazz Pharmaceuticals PlcBruce C. Cozadd - Jazz Pharmaceuticals PlcMatthew P. Yo
Nov 06, 2018 - Jazz (JAZZ) delivered earnings and revenue surprises of 7.51% and -2.65%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Nov 06, 2018 - The following slide deck was published by Jazz Pharmaceuticals, Inc. in conjunction with their 2018 Q3 earnings call.